The FDA has approved Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.
“This first-to-market launch for the store brand is the testament to the deep capabilities of our store brand OTC business,” says Milan Kalawadia, Vice President and Head, US Over-the-Counter and Speciality Rx businesses, Dr. Reddy’s Laboratories. “We look forward to collaborating with our customers to bring high-quality, affordable store brand alternatives to the market.”
The Xyzal Allergy 24HR Tablets brand had U.S. sales of approximately $71 million for the most recent twelve months ending in January 2018 according to IRI.
Dr. Reddy’s Levocetirizine Dihydrochloride Tablets USP is available in 5 mg strength and in various consumer oriented package sizes.
(Source: Dr. Reddy’s Laboratories Ltd.)
Filed Under: Drug Discovery
